Dividendes sectoriels Sun Pharmaceutical Industries Ltd. Bombay S.E.
Actions
SUNPHARMA
INE044A01036
Produits pharmaceutiques
|
Marché Fermé -
Bombay S.E.
12:22:26 21/08/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 1 900,90 INR | -0,01% |
|
-1,25% | +10,53% |
| 05/08 | CRISIL maintient la note AAA pour les facilités bancaires de Sun Pharmaceutical | MT |
| 31/07 | Transcript : Sun Pharmaceutical Industries Limited, Q1 2027 Earnings Call, Jul 31, 2026 |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Rendement du dividende (Y) | Rendement du dividende (Y+1) | PER (Y) | Price to Book (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
| 0,9% | 1,04% | 35.1x | 4.92x | 6.58x | 22.81x | 27.59x | 47,71 Md | ||
| 1,39% | 1,47% | 18.6x | 1.96x | 2.22x | 10.04x | 12.93x | 40,3 Md | ||
| 0,91% | 1,03% | 27.88x | 3.08x | 3.39x | 17.57x | 22.53x | 12,09 Md | ||
| 0,6% | 0,64% | 26.85x | 3.7x | 3.84x | 15.92x | 22.29x | 11,68 Md | ||
| 3,85% | 3,94% | 18.73x | 3.25x | 3.33x | 11.58x | 13.79x | 9,19 Md | ||
| 4,46% | 5,19% | 9.03x | 1.55x | 2.08x | 5.42x | 6.68x | 7,57 Md | ||
| 3,2% | 3,17% | 15.95x | 1.31x | 2.08x | 6.76x | 9.72x | 7,24 Md | ||
| 0,16% | 0,17% | 28.19x | 5.17x | 3.68x | 17.11x | 20.62x | 6,84 Md | ||
| 0,92% | 1,05% | 36.23x | 8.39x | 7.08x | 25.83x | 28.52x | 4,75 Md | ||
| 3,42% | 3,93% | 15.16x | 2.53x | 2.51x | 11.44x | 11.3x | 3,96 Md | ||
| 1,8% | 1,7% | 15x | 0.73x | 2.08x | 8.92x | 11.29x | 4,09 Md | ||
| 2,69% | 2,76% | 14.72x | 2.97x | 3.43x | 12.8x | 14.14x | 2,93 Md | ||
| 2,96% | 3,42% | 20.26x | 5.16x | 5.76x | 17.41x | 19.08x | 2,62 Md | ||
| Moyenne | 2,1% | 2,27% | 21,67x | 3,44x | 3,70x | 14,12x | 16,96x | 12,38 Md | |
| Moyenne pondérée par Capi. | 1,56% | 1,7% | 24,93x | 3,45x | 4,06x | 15,48x | 19,12x |
- Bourse
- Actions
- Action SUNPHARMA
- Action SUNPHARMA
- Secteur Sun Pharmaceutical Industries Ltd.
- Dividendes sectoriels
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















